Archive for News Report
Renovia Closes on $42 Million Series B with CEO Marc Beer
A promising new minimally invasive procedure for skin contouring
GlaxoSmithKline Helps Immunometabolism Startup Sitryx to $30M Round
Verastem Wins FDA Approval for Blood Cancer Drug
Needham-based Verastem Oncology won its first drug approval Monday, a medicine that treats three forms of blood cancer.